Redeye remains positive towards Avensia following a Q1 report largely matching our forecasts. We get the impression that a slight market uptick is more likely than a further decline, although the most likely scenario is an unchanged market. We keep our Base Case unchanged and the discount to peers remains significant.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

Avensia - Stable Performance in Challenging Market

© Modular Finance, source Nordic Press Releases